MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

27.77 +0.73 (+2.70%)
Official Closing Price Updated: 7:00 PM EDT, Jul 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
56 57 Next >
News headline image
MarketBeat Week in Review – 05/19 - 05/23
Stocks were moving lower to end the week as tariff concerns returned; however NVIDIA earnings next week may help investors climb the wall of worry 
Via MarketBeat
Topics Artificial Intelligence Bonds Economy
News headline image
8 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Why Hims & Hers Health (HIMS) Stock Is Falling Today
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 6.3% in the afternoon session after Cigna Group's Evernorth division introduced a monthly $200 price cap for weight-loss medications... 
Via StockStory
Topics Artificial Intelligence
News headline image
Hims & Hers Introduces 6-Month Wegovy® New Customer Offer
From Hims & Hers
Via Business Wire
News headline image
Will Hims & Hers Stock Be Okay After UnitedHealth's Sell-Off?
The UnitedHealth stock sell-off might have spooked investors in the medical sector, who are wondering if it will affect shares of Hims & Hers equally. 
Via MarketBeat
Topics Government World Trade
News headline image
Hims & Hers Stock Drops After Evernorth Announces Cheaper Pricing For Weight-Loss Drugs: Retail’s Dull ↗
Truist noted on Thursday that the $200/month price point is "highly attractive compared to other price points in the market," including Hims & Hers' compounded Semaglutide, Wegovy, and Liraglutide... 
Via Stocktwits
News headline image
Hims & Hers Health Stock Is Tumbling Thursday: What's Happening? ↗
Hims & Hers Health, Inc (NYSE:HIMS) is facing heavy selling pressure Thursday morning as the U.S. Food and Drug Administration's (FDA) ban of compounded drugs with semaglutide takes effect. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Up 157% in 2025, Is It Too Late to Buy Hims & Hers Stock? ↗
Via The Motley Fool
News headline image
Envista, NeoGenomics, Acadia Healthcare, Astrana Health, and Hims & Hers Health Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after the major pulled back (Nasdaq -1.3%, S&P 500 - 1.4%) as Treasury yields rose, reflecting market anxiety over a draft federal budget that could... 
Via StockStory
Topics Bonds Stocks
News headline image
Treasury Yields Top 5%: These 20 Stocks Tanked In Just One Hour ↗
The selloff came as investors repriced risk across equities amid fears of persistently higher rates, sparked by soft demand at the 20-year Treasury auction. 
Via Benzinga
News headline image
Unpacking Q1 Earnings: Hims & Hers Health (NYSE:HIMS) In The Context Of Other Healthcare Technology Stocks
Looking back on healthcare technology stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Hims & Hers Health (NYSE:HIMS) and its peers. 
Via StockStory
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Hims & Hers Stock Chart Points to Strong Bullish Continuation
Hims & Hers Health, Inc. stock price action shows strongly bullish signs in May and could be ready to hit new highs before the 2nd half starts. 
Via MarketBeat
News headline image
CoreWeave, Super Micro Computer And Coinbase Are Among Top 11 Large-Cap Gainers Last Week (May 12-May 16): Are The Others In Your Portfolio? ↗
Large-cap stocks surged in the last week. CoreWeave, Super Micro, Coinbase, NRG Energy, Astera Labs, First Solar, Exelixis, Rocket Lab, Hims & Hers, On Holding and Gap were the top performers. 
Via Benzinga
News headline image
9 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Hims & Hers Stock Pulls Back After Strong Q1 Earnings, 115% Gain Over Past Month ↗
Hims & Hers Health shares fell 4.1% Wednesday morning. Despite the pullback, the stock remains up an impressive 116% over the past month. 
Via Benzinga
News headline image
HIMS & HERS HEALTH INC (NYSE:HIMS) – A High-Growth Stock Meeting Minervini’s Trend Template ↗
HIMS & HERS HEALTH (NYSE:HIMS) meets Minervini’s Trend Template with strong technicals and explosive earnings growth, making it a high-growth momentum candidate. 
Via Chartmill
News headline image
Hims & Hers Stock Sparks Retail Trader Frenzy After CEO Announces 'Largest Raise Yet' Of $1B ↗
CEO Andrew Dudum said it was “more than double what we set out for,” thanks to strong investor demand. 
Via Stocktwits
Topics Artificial Intelligence Regulatory Compliance
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Hims & Hers Stock Soars 29% On Strong Q1 Earnings, Subscriber Growth ↗
Shares of Hims & Hers have gained 29% over the past week. The move higher has been driven by an impressive Q1 earnings report released last week. 
Via Benzinga
News headline image
2 No-Brainer Growth Stocks to Buy Right Now ↗
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
Market Monitor News May 12 ( NRG Energy, Amazon, Meta Platforms UP - CVS Health DOWN) ↗
Wall Street surges sharply as US-China tariff cuts drive tech stocks higher; pharma sector gains on new Trump drug pricing initiative. 
Via Chartmill
Topics Government World Trade
News headline image
Big News! U.S. and China Trade Deal Shakes Up Markets ↗
Stocks are soaring today on the hope that the trade tensions between the U.S. and China are behind us. 
Via The Motley Fool
Topics World Trade
News headline image
Unlocking the Growth Potential of HIMS & HERS HEALTH INC (NYSE:HIMS). ↗
A fundamental analysis of (NYSE:HIMS): HIMS & HERS HEALTH INC (NYSE:HIMS) showing high EPS and FCF growth while beating expectations 
Via Chartmill
News headline image
Trump's Drug Price Slash Plan Sparks Retail Buzz As Investors Eye Big Pharma Fallout ↗
The proposal, citing a "Most Favored Nation Policy," fueled debate prompted some watchers to question the legality and feasibility of the move, while others speculated on its potential market impact. 
Via Stocktwits
Topics ETFs Government Stocks
News headline image
Retail Bulls Face Off With Record Shorts In Hims & Hers After Q1 Beat ↗
Short interest in Hims & Hers rose to a record high of 37%, continuing a four-week climb, even as the stock surged 42% last week. The company’s quarterly revenue more than doubled, surpassing analyst... 
Via Stocktwits
Topics Earnings
News headline image
The Trade Desk, Walt Disney, And Hims & Hers Health Are Among Top 11 Large-Cap Gainers Last Week (May 5-May 9): Are The Others In Your Portfolio? ↗
Top-performing large-cap stocks last week: TTD, HIMS, PODD, FTAI, ULS, UI, ROK, TOST, DIS, MCHP, and ARMK. Analysts raised price forecasts. 
Via Benzinga
News headline image
Benzinga Bulls And Bears: IBM, Novavax, Arm Holdings — And UK Trade Deal Boosts Markets ↗
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories. 
Via Benzinga
News headline image
Massive Hims & Hers News: $1 Billion on AI and Acquisitions ↗
Hims & Hers is getting $1 billion of rocket fuel. 
Via The Motley Fool
Topics Artificial Intelligence
< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
56 57 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story